Open original FDA record ↗Recall record
- FDA identifier
- Z-1924-2017
- Company in FDA record
- Natus Medical Incorporated
- FDA classification date
- Apr 14, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The second generation neoBLUE 2 lights with a black band, sold from 2003 to 2008, are recalled so it will eliminate the possibility that a neoBLUE system may have a replacement board installed which allows it to be used at a higher overall light intensity than the devices were originally cleared to deliver.
Source facts
- Action
- On April 3, 2017, Natus sent the URGENT: RECALL NOTIFICATION 2nd Generation neoBLUE LED Phototherapy Systems letter, dated March 2017, and the Reply Form to the U.S. customers. U.S. Customers are advised to follow four steps process to receive replacement lights and return affected light back to Natus in Seattle, WA for destruction. Customers should scan and email completed Reply Form to Natus_Quality_Programs@natus.com or FAX to 847-949-6031. On April 4, 2017, Natus sent the URGENT MEDICAL DEVICE RECALL/EXCHANGE 2nd Generation neoBLUE LED Phototherapy Systems letter, dated March 2017, Reply Form, Instructions to Disable neoBLUE 2 Light, neoBLUE 2 Systems Serial Number List For Their Territory to international Distribution Partners. Downstream international customers are instructed to return the affected neoBLUE lights to their Distribution Partners. International Distribution Partners follow the Instructions to Disable neoBLUE2 lights (DOC- 019983 rev A) and destroy all affected neoBLUE lights that they recover from downstream international customers. Distribution Partners can contact Natus Technical Service at 1-888-496-2887, or e-mail the Reply Form to Natus_Quality_Programs@natus.com or via fax to 847-949-6031.
- Initiated
- 2017-04-03
- Root cause
- Component change control
- Terminated
- 2019-08-13
- Distribution
- Worldwide Distribution - US Nationwide and in the following countries: Argentina, Australia, Austria, Belgium, Bermuda, Canada, Colombia, Croatia, Denmark, Germany, Greece, Hungary, India, Indonesia, Israel, Italy, Japan, Kenya, Kuwait, Lithuania, Morocco, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, United Arab Emirates, United Kingdom, and Virgin Islands (British).
- Recall number
- Z-1924-2017
- Recall status
- Terminated
- CDRH record ID
- 147739
- FDA classified
- 2017-04-14
- Recall event number
- 74474